Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
about
Enteric microbiome metabolites correlate with response to simvastatin treatmentA genome-wide metabolic QTL analysis in Europeans implicates two loci shaped by recent positive selectionMetabolomics reveals amino acids contribute to variation in response to simvastatin treatmentPlacing epidemiological results in the context of multiplicity and typical correlations of exposuresThe human microbiome: our second genomeIntestinal microbial metabolism of phosphatidylcholine and cardiovascular riskIntestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosisExposure science and the exposome: an opportunity for coherence in the environmental health sciencesFrom hepatoprotection models to new therapeutic modalities for treating liver diseases: a personal perspectiveThe Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular DiseaseMucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel DiseaseThe gut microbiome in human immunodeficiency virus infectionMetagenomics, Metatranscriptomics, and Metabolomics Approaches for Microbiome AnalysisA healthy gastrointestinal microbiome is dependent on dietary diversityVascular Damage in Patients with Nonalcoholic Fatty Liver Disease: Possible Role of Iron and FerritinMicrobial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventionsProbiotics and Prebiotics: Present Status and Future Perspectives on Metabolic DisordersGut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of MetabolomicsThe New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome TransplantationProbiotics and blood pressure: current insightsProbiotics in prevention and treatment of obesity: a critical viewMaking the Leap from Research Laboratory to Clinic: Challenges and Opportunities for Next-Generation Sequencing in Infectious Disease DiagnosticsThe enteric microbiome in hepatobiliary health and diseaseSystematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infectionsBioactive Egg Components and InflammationXenobiotics: Interaction with the Intestinal MicrofloraMetagenomic surveys of gut microbiotaIncreased Intake of Foods with High Nutrient Density Can Help to Break the Intergenerational Cycle of Malnutrition and ObesityRole of gut microbiota in the modulation of atherosclerosis-associated immune responseGut microbes and host physiology: what happens when you host billions of guests?Listening to Our Gut: Contribution of Gut Microbiota and Cardiovascular Risk in Diabetes PathogenesisMetabolomics: A Tool Ahead for Understanding Molecular Mechanisms of Drugs and DiseasesThe contributory role of gut microbiota in cardiovascular diseaseMicrobiome analysis - from technical advances to biological relevanceAssessing the human gut microbiota in metabolic diseasesArchaea in and on the Human Body: Health Implications and Future DirectionsApproaches to uremiaA new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretionIdentifying novel biomarkers for cardiovascular disease risk predictionInvestigating potential mechanisms of obesity by metabolomics
P2860
Q21135141-DD83D8DD-FAB8-42E0-ADB7-7CF5449E5C88Q21144941-EF687424-73A0-4179-8835-899E0B310536Q21561017-E4F871AA-5626-4F2A-AD03-D31C70E57676Q24289033-D3C25F12-63EB-4E75-B0A4-D3AEEF3FF3C9Q24601696-2710531F-9D1E-4E2D-892F-66627AB719AAQ24603491-D8293020-DFEA-40D8-9D29-27C8A126C7BDQ24629045-5FE12FCA-65AC-4CD0-A4D2-9F395960502FQ24633688-A2C69364-ABEE-4FD6-B946-7683C3032AE7Q26738626-C7169C57-940A-4130-B64F-6D5EE1C44D4BQ26739993-044AF4E7-67E3-4DFC-B082-0DB6D39A91DEQ26741117-E331F669-DBB8-4670-9E45-8166944A79E8Q26743543-152B6282-31DF-47FD-B96F-18F990413A10Q26747593-DA9036E2-66D8-44C4-ABBC-12280B3BAEC5Q26750607-DF0E186A-4870-494C-8FD3-1A3B9B7CEE23Q26750865-0116EEC3-93A0-4C6F-9D31-D63D74B30AB1Q26751203-65B49420-4B98-431B-B321-DECBE1677606Q26752979-E0288CDA-4A32-48D4-BD02-61299F480FB4Q26753047-4F61BE56-475B-4EF0-A3B6-7C72246304E3Q26765740-0F6994CA-24E6-4646-9485-6E38FBA258A0Q26767248-E8DC1C43-DA87-4D6A-891D-C1B9312A8785Q26768518-3C9D5C2A-A5A8-49FE-906E-51575199779CQ26773525-6DAD39FE-B959-45F8-998F-A1808E3D01A1Q26777426-6A29930B-5614-443A-8CD4-F9A69F703B32Q26782662-2828BCB5-355B-49F1-BAB8-2AD062BE387BQ26782731-1E624722-BEC1-4DEB-A38C-060FF1D36481Q26795702-79E8B7C1-435F-448F-BD8A-718F1AFAA455Q26799820-5E485472-981E-40FC-BEE6-7710AECA258DQ26801379-8C31C676-6D6D-4A04-A892-B9399416CC41Q26801649-A97B7282-7821-4441-8981-F6FA3C4A7209Q26822836-87C0ED3A-A2FC-455D-8A4D-06B981B5742EQ26823198-9675721F-C4E9-4506-A5A8-A20ED5B1EC77Q26827107-121335A3-4255-4798-8F87-F25ECD47425EQ26830828-4DF4B091-4051-4E96-AC45-414B9D2DD56BQ26849411-BC435B47-DB73-4A20-9235-E7B183EA21B8Q26860785-F009F488-B73D-4A95-93DB-15E447AF5CE5Q26863524-0C99FC6A-A107-4600-8A50-9176F11251BBQ26864807-9842DE4F-A034-4851-8E9D-EF80F169DD8EQ26865600-EFFBEB61-55F1-48B6-BDB2-E1391002B266Q26865722-36BC70F9-38BF-4DDC-96F2-772EB2DF9410Q26865774-57A43DB1-C1FD-4E9F-8C4E-30E155870F98
P2860
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
@ast
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
@en
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
@nl
type
label
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
@ast
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
@en
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
@nl
prefLabel
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
@ast
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
@en
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
@en
P2093
Ariel E Feldstein
Brandon Dugar
Brian J Bennett
Earl B Britt
Elizabeth Klipfell
Hooman Allayee
Joseph A DiDonato
Phil Schauer
Robert Koeth
Stanley L Hazen
P2860
P2888
P3181
P356
10.1038/NATURE09922
P407
P577
2011-04-07T00:00:00Z
P5875
P6179
1043309820